• Composition

- Tafluprost 0.015 mg

  • Indications
  • Reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.
  • As monotherapy in patients:
  • Who would benefit from preservative free eye drops.
  • Insufficiently responsive to first line therapy.
  • Intolerant or contra-indicated to first line therapy.
  • As adjunctive therapy to beta-blockers.



  • The recommended dose is one drop of TAFLUPRO in the conjunctival sac of the affected eye(s) once daily in the evening.
  • Volume

6 plastic strips each of 5 (LDPE) plastic single dose units, each unit contains 0.3 ml ophthalmic solution.